Novavax | NVAX - DETTE

Prix De L'Action
9.73
Variation Quotidienne
0.11 1.09%
Mensuellement
2.80%
Annuel
26.46%
Q1 Prévisions
9.33




DETTE Changement Date
Adma Biologics USD 83.12M 702K 2025-09
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 32.63B 207M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Cassava Sciences USD 0 0 2024-12
Geron USD 121.92M 73K 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
MannKind USD 119.91M 73.09M 2025-09
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 734M 7M 2025-09
Novartis USD 32.02B 615M 2025-09
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 60.85B 78M 2025-09
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
TG Therapeutics USD 245.34M 8.38M 2025-09